Efficacy of Biocage in treating single-segment lumbar degenerative disease in patients with high risk of non-fusion: a prospective controlled study with at least 2 years’ follow-up

OBJECTIVE: To evaluate the clinical efficacy of an allogeneic bone cage (Biocage; Beijing Datsing Bio-Tech Co., Ltd., Beijing, China) for treatment of single-segment lumbar degenerative disease in patients with a high risk of non-fusion. METHODS: From January 2013 to December 2016, 67 patients who u...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yang, Yu, Yang, Hou, Tian-yong, Zhang, Ze-hua, Xing, Jun-chao, Lu, Hong-wei, Zhou, Rui, Cheng, Peng, Xu, Jian-Zhong, Wu, Wen-jie, Luo, Fei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Prospective Clinical Research Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7518008/
https://www.ncbi.nlm.nih.gov/pubmed/32962480
http://dx.doi.org/10.1177/0300060520945500

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7518008/
https://www.ncbi.nlm.nih.gov/pubmed/32962480
http://dx.doi.org/10.1177/0300060520945500

Ejemplares similares